Cystic Fibrosis Channel
Topics & Medications
Related Channels

Kalydeco and Breastfeeding

No research has been done to determine if Kalydeco (ivacaftor) would pass through human breast milk, or if it would be harmful to a nursing infant. However, studies have shown that this drug does pass through breast milk in rats. To help ensure the safest treatment possible, it's a good idea to talk to your healthcare provider before using Kalydeco while breastfeeding.

Can Breastfeeding Women Take Kalydeco?

Kalydeco™ (ivacaftor) is a prescription cystic fibrosis medication. At this time, it is unknown if the drug passes through breast milk. Therefore, make sure to ask your healthcare provider about the possible risks and benefits before taking Kalydeco while nursing.

More Information About Kalydeco and Breastfeeding

Research has shown that Kalydeco passes through breast milk in rats. However, it is unknown whether the drug would pass through breast milk in humans, or if it would cause any problems in a nursing infant. Before deciding to breastfeed while taking Kalydeco, make sure to discuss this with your healthcare provider as well as your child's healthcare provider. Also, be on the lookout for any possible Kalydeco side effects in your child.

Talking With Your Healthcare Provider

You should discuss breastfeeding and Kalydeco use with your healthcare provider. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, the two of you can make a shared decision that is right for you.
Baby Milestones You've Never Heard Of

Kalydeco Medication Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2020 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.